Attractive study of the antimicrobial, antiviral, and cytotoxic activity of novel synthesized silver chromite nanocomposites

Table 6 Antiviral activity of compound 15 N against Hepatitis A virus

Treatment	MNCC (µg/ml)	Antiviral effect on HAV (%)	Antiviral effect on HAV (Qualitative)#	Antiviral Efficiency
Treatment	MNCC (µg/ml)	Antiviral effect on HAV (%)	Antiviral effect on HAV (Qualitative)#	EC50	CC50	SI
Amantadine (control)	130	86.91 ± 5.57	++++	8.48 ± 0.50	325.61 ± 16.9	38.39
15 N	60	7.24 ± 0.64*	+	408.14 ± 21.60*	280.36 ± 19.3*	0.69

Data is displayed as mean (n = 3) ± standard deviation
^*: represents significant difference (P < 0.05), as compared to the corresponding controls, according to independent t-test. #Where: (+): Weak antiviral activity (1- < 25%), and (++++): Excellent antiviral activity (75–100%)
Where: ( +): Weak antiviral activity (1– < 25%), and (++++): Excellent antiviral activity (75–100%)

ISSN: 2661-801X